Gastritis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: G5294373AF45EN
Market Monitor Global

Abstracts

Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Others possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.

This report contains market size and forecasts of Gastritis Treatment in Global, including the following market information:

Global Gastritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gastritis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acid-Blocking Medicines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gastritis Treatment include Pfizer, AstraZeneca, Novartis, Cipla, Abbott Laboratories, Microbiotix, Reddy's Laboratories, Lupin Ltd and Perrigo Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gastritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gastritis Treatment Market Segment Percentages, by Type, 2021 (%)

• Acid-Blocking Medicines
• Antibiotics
• Antacids
• Histamine Blockers
• Others

Global Gastritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gastritis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Gastritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gastritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gastritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gastritis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• AstraZeneca
• Novartis
• Cipla
• Abbott Laboratories
• Microbiotix
• Reddy's Laboratories
• Lupin Ltd
• Perrigo Pharmaceutical
• Sun Pharmaceutical Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gastritis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gastritis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GASTRITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Gastritis Treatment Market Size: 2021 VS 2028
2.2 Global Gastritis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gastritis Treatment Players in Global Market
3.2 Top Global Gastritis Treatment Companies Ranked by Revenue
3.3 Global Gastritis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gastritis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gastritis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastritis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Gastritis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gastritis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gastritis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Acid-Blocking Medicines
  4.1.3 Antibiotics
  4.1.4 Antacids
  4.1.5 Histamine Blockers
  4.1.6 Others
4.2 By Type - Global Gastritis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Gastritis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Gastritis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Gastritis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gastritis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Gastritis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Gastritis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Gastritis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Gastritis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gastritis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Gastritis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Gastritis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Gastritis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Gastritis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gastritis Treatment Revenue, 2017-2028
  6.3.2 US Gastritis Treatment Market Size, 2017-2028
  6.3.3 Canada Gastritis Treatment Market Size, 2017-2028
  6.3.4 Mexico Gastritis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gastritis Treatment Revenue, 2017-2028
  6.4.2 Germany Gastritis Treatment Market Size, 2017-2028
  6.4.3 France Gastritis Treatment Market Size, 2017-2028
  6.4.4 U.K. Gastritis Treatment Market Size, 2017-2028
  6.4.5 Italy Gastritis Treatment Market Size, 2017-2028
  6.4.6 Russia Gastritis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Gastritis Treatment Market Size, 2017-2028
  6.4.8 Benelux Gastritis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gastritis Treatment Revenue, 2017-2028
  6.5.2 China Gastritis Treatment Market Size, 2017-2028
  6.5.3 Japan Gastritis Treatment Market Size, 2017-2028
  6.5.4 South Korea Gastritis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Gastritis Treatment Market Size, 2017-2028
  6.5.6 India Gastritis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gastritis Treatment Revenue, 2017-2028
  6.6.2 Brazil Gastritis Treatment Market Size, 2017-2028
  6.6.3 Argentina Gastritis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gastritis Treatment Revenue, 2017-2028
  6.7.2 Turkey Gastritis Treatment Market Size, 2017-2028
  6.7.3 Israel Gastritis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Gastritis Treatment Market Size, 2017-2028
  6.7.5 UAE Gastritis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Gastritis Treatment Major Product Offerings
  7.1.4 Pfizer Gastritis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Gastritis Treatment Major Product Offerings
  7.2.4 AstraZeneca Gastritis Treatment Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Gastritis Treatment Major Product Offerings
  7.3.4 Novartis Gastritis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla Gastritis Treatment Major Product Offerings
  7.4.4 Cipla Gastritis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Cipla Key News
7.5 Abbott Laboratories
  7.5.1 Abbott Laboratories Corporate Summary
  7.5.2 Abbott Laboratories Business Overview
  7.5.3 Abbott Laboratories Gastritis Treatment Major Product Offerings
  7.5.4 Abbott Laboratories Gastritis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Abbott Laboratories Key News
7.6 Microbiotix
  7.6.1 Microbiotix Corporate Summary
  7.6.2 Microbiotix Business Overview
  7.6.3 Microbiotix Gastritis Treatment Major Product Offerings
  7.6.4 Microbiotix Gastritis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Microbiotix Key News
7.7 Reddy's Laboratories
  7.7.1 Reddy's Laboratories Corporate Summary
  7.7.2 Reddy's Laboratories Business Overview
  7.7.3 Reddy's Laboratories Gastritis Treatment Major Product Offerings
  7.7.4 Reddy's Laboratories Gastritis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Reddy's Laboratories Key News
7.8 Lupin Ltd
  7.8.1 Lupin Ltd Corporate Summary
  7.8.2 Lupin Ltd Business Overview
  7.8.3 Lupin Ltd Gastritis Treatment Major Product Offerings
  7.8.4 Lupin Ltd Gastritis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Lupin Ltd Key News
7.9 Perrigo Pharmaceutical
  7.9.1 Perrigo Pharmaceutical Corporate Summary
  7.9.2 Perrigo Pharmaceutical Business Overview
  7.9.3 Perrigo Pharmaceutical Gastritis Treatment Major Product Offerings
  7.9.4 Perrigo Pharmaceutical Gastritis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Perrigo Pharmaceutical Key News
7.10 Sun Pharmaceutical Industries
  7.10.1 Sun Pharmaceutical Industries Corporate Summary
  7.10.2 Sun Pharmaceutical Industries Business Overview
  7.10.3 Sun Pharmaceutical Industries Gastritis Treatment Major Product Offerings
  7.10.4 Sun Pharmaceutical Industries Gastritis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Sun Pharmaceutical Industries Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gastritis Treatment Market Opportunities & Trends in Global Market
Table 2. Gastritis Treatment Market Drivers in Global Market
Table 3. Gastritis Treatment Market Restraints in Global Market
Table 4. Key Players of Gastritis Treatment in Global Market
Table 5. Top Gastritis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gastritis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gastritis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gastritis Treatment Product Type
Table 9. List of Global Tier 1 Gastritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gastritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gastritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gastritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gastritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gastritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gastritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gastritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gastritis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gastritis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gastritis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gastritis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gastritis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gastritis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gastritis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gastritis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gastritis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gastritis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gastritis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gastritis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Gastritis Treatment Product Offerings
Table 32. Pfizer Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Gastritis Treatment Product Offerings
Table 35. AstraZeneca Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Gastritis Treatment Product Offerings
Table 38. Novartis Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla Gastritis Treatment Product Offerings
Table 41. Cipla Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories Gastritis Treatment Product Offerings
Table 44. Abbott Laboratories Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Microbiotix Corporate Summary
Table 46. Microbiotix Gastritis Treatment Product Offerings
Table 47. Microbiotix Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Reddy's Laboratories Corporate Summary
Table 49. Reddy's Laboratories Gastritis Treatment Product Offerings
Table 50. Reddy's Laboratories Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Lupin Ltd Corporate Summary
Table 52. Lupin Ltd Gastritis Treatment Product Offerings
Table 53. Lupin Ltd Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Perrigo Pharmaceutical Corporate Summary
Table 55. Perrigo Pharmaceutical Gastritis Treatment Product Offerings
Table 56. Perrigo Pharmaceutical Gastritis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Sun Pharmaceutical Industries Corporate Summary
Table 58. Sun Pharmaceutical Industries Gastritis Treatment Product Offerings
Table 59. Sun Pharmaceutical Industries Gastritis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gastritis Treatment Segment by Type in 2021
Figure 2. Gastritis Treatment Segment by Application in 2021
Figure 3. Global Gastritis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gastritis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastritis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastritis Treatment Revenue in 2021
Figure 8. By Type - Global Gastritis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gastritis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gastritis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gastritis Treatment Revenue Market Share, 2017-2028
Figure 12. US Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gastritis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gastritis Treatment Revenue Market Share, 2017-2028
Figure 24. China Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gastritis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gastritis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gastritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Laboratories Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Microbiotix Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Reddy's Laboratories Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lupin Ltd Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Perrigo Pharmaceutical Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sun Pharmaceutical Industries Gastritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)